Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Tumor Microenvironment in Ovarian Cancer

Study of the Role of the Tumor Microenvironment in Ovarian Cancer

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

A detailed understanding of molecular mechanism of cancer genesis is fundamental to develop innovative and personalized therapies. The new frontier in biomedical research is represented by organoids, a three-dimensional cell culture system obtained from a tissue fragment that accurately reproduces the essential properties of the original tissue in vitro, which could provide a valuable model for explanation of ovarian cancers pathogenesis and will allow to predict the response to a specific therapy. With this research project, we expect to generate ovarian cancer organoids to characterize in vitro interactions and molecular pathway among tumor cells, immune cells, and resident microbiota (intratumoral bacteria and/or microbial-derived molecules).

Who May Be Eligible (Plain English)

Who May Qualify: - Age \> 18 years - Age \< 80 years - Serous ovarian carcinoma - FIGO Stage III-IV Who Should NOT Join This Trial: - Ongoing or suspended immunosuppressive therapy within the last 6 months - Congenital or acquired weakened immune system - Immunosuppressive state - Administration of chemotherapy for another neoplasm in the past 12 months - Non-epithelial ovarian tumors - Patients not undergoing surgical intervention - BMI \> 30 - Absence of willing to sign a consent form Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age \> 18 years * Age \< 80 years * Serous ovarian carcinoma * FIGO Stage III-IV Exclusion Criteria: * Ongoing or suspended immunosuppressive therapy within the last 6 months * Congenital or acquired immunodeficiency * Immunosuppressive state * Administration of chemotherapy for another neoplasm in the past 12 months * Non-epithelial ovarian tumors * Patients not undergoing surgical intervention * BMI \> 30 * Absence of Informed Consent

Treatments Being Tested

OTHER

Ovarian Cancer Organoids

To characterize in vitro interactions and molecular pathway among tumor cells, immune cells, and resident microbiota (intratumoral bacteria and/or microbial-derived molecules)

Locations (1)

Università degli Studi di Udine
Udine, UD, Italy